1. Home
  2. IMTX vs LAB Comparison

IMTX vs LAB Comparison

Compare IMTX & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMTX
  • LAB
  • Stock Information
  • Founded
  • IMTX N/A
  • LAB 1999
  • Country
  • IMTX Germany
  • LAB United States
  • Employees
  • IMTX N/A
  • LAB N/A
  • Industry
  • IMTX Biotechnology: Biological Products (No Diagnostic Substances)
  • LAB Biotechnology: Laboratory Analytical Instruments
  • Sector
  • IMTX Health Care
  • LAB Industrials
  • Exchange
  • IMTX Nasdaq
  • LAB Nasdaq
  • Market Cap
  • IMTX N/A
  • LAB 562.1M
  • IPO Year
  • IMTX N/A
  • LAB 2011
  • Fundamental
  • Price
  • IMTX $4.51
  • LAB $1.08
  • Analyst Decision
  • IMTX Strong Buy
  • LAB Strong Buy
  • Analyst Count
  • IMTX 4
  • LAB 3
  • Target Price
  • IMTX $16.67
  • LAB $2.88
  • AVG Volume (30 Days)
  • IMTX 692.6K
  • LAB 1.5M
  • Earning Date
  • IMTX 03-27-2025
  • LAB 05-07-2025
  • Dividend Yield
  • IMTX N/A
  • LAB N/A
  • EPS Growth
  • IMTX N/A
  • LAB N/A
  • EPS
  • IMTX 0.14
  • LAB N/A
  • Revenue
  • IMTX $161,336,577.00
  • LAB $174,432,000.00
  • Revenue This Year
  • IMTX $116.22
  • LAB N/A
  • Revenue Next Year
  • IMTX N/A
  • LAB $12.77
  • P/E Ratio
  • IMTX $31.94
  • LAB N/A
  • Revenue Growth
  • IMTX 188.60
  • LAB 64.03
  • 52 Week Low
  • IMTX $4.06
  • LAB $0.99
  • 52 Week High
  • IMTX $13.77
  • LAB $3.04
  • Technical
  • Relative Strength Index (RSI)
  • IMTX 41.98
  • LAB 39.47
  • Support Level
  • IMTX $4.46
  • LAB $1.11
  • Resistance Level
  • IMTX $5.21
  • LAB $1.21
  • Average True Range (ATR)
  • IMTX 0.34
  • LAB 0.07
  • MACD
  • IMTX -0.00
  • LAB 0.01
  • Stochastic Oscillator
  • IMTX 12.50
  • LAB 14.24

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Share on Social Networks: